Analysts are estimating that Neurocrine Biosciences will report an earnings per share (EPS) of $2.09.
Neurocrine Biosciences bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Historical Earnings Performance
During the last quarter, the company reported an EPS beat by $0.30, leading to a 6.35% drop in the share price on the subsequent day.
Here's a look at Neurocrine Biosciences's past performance and the resulting price change:
Quarter
Q3 2025
Q2 2025
Q1 2025
Q4 2024
EPS Estimate
1.87
1.27
1.09
1.71
EPS Actual
2.17
1.65
0.70
1.69
Price Change %
-6.00
-6.00
8.00
-19.00
Neurocrine Biosciences Share Price Analysis
Shares of Neurocrine Biosciences were trading at $139.56 as of February 09. Over the last 52-week period, shares are up 21.74%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Insights Shared by Analysts on Neurocrine Biosciences
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Neurocrine ...
